Hormone replacement therapy and cancer.
The benefits of hormone replacement therapy in alleviating climacteric symptoms, preventing osteoporosis and reducing the incidence of cardiovascular disease and stroke are now generally agreed. Nonetheless, perhaps only 5% of postmenopausal women currently receive adequate treatment often because of patient or clinician fears that such treatment may be associated with harmful side effects.
Baber
R J
RJ
Dulwich Hospital, London.
Studd
J W
JW
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000139:chemically induced; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D045166:Estradiol Congeners / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005833:Genital Neoplasms, Female / Q000139:chemically induced; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D009369:Neoplasms / Q000139:chemically induced*; D010024:Osteoporosis / Q000517:prevention & control; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D045166:Estradiol Congeners; D045167:Progesterone Congeners